Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.63 |
| ▸ | PPARG | P37231 | 3/20 | 0.63 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | ACACB | O00763 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | VHL | P40337 | 1/20 | 0.34 |
| ▸ | ELOC | Q15369 | 1/20 | 0.34 |
| ▸ | ELOB | Q15370 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL28244815 | 0.83 | PPARA (0.44) | PPARAPPARGACACBTSHRTRPV1 | |
| SCHEMBL934447 | 0.83 | PPARA (0.59) | PPARAPPARGLTA4HTSHRELANE | |
| SCHEMBL6667517 | 0.83 | PPARA (0.66) | PPARAPPARGACACBTSHRHRH3 | |
| SCHEMBL11054493 | 0.83 | PPARG (0.59) | PPARAPPARGLTA4HTSHRELANE | |
| SCHEMBL197077 | 0.81 | ELANE (0.50) | PPARAPPARGLTA4HACACBTSHR | |
| SCHEMBL26746 | 0.80 | SLC6A2 (0.44) | PPARAPPARGACACBTSHRELANE | |
| SCHEMBL3451212 | 0.79 | PPARA (0.68) | PPARAPPARGLTA4HACACBEPHX2 | |
| SCHEMBL1126574 | 0.79 | SMN1; SMN2 (0.42) | PPARAPPARGACACBTSHR | |
| SCHEMBL19755194 | 0.78 | PPARG (0.42) | PPARAPPARGACACBELANEEPHX2 | |
| SCHEMBL9996916 | 0.78 | PPARG (1.00) | PPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504372-A | Method for synthesizing 4-tert-butoxy styrene | 西安近代化学研究所 | 2025-02-25 | — | — | CN | claimed |
| EP-0059372-A1 | Process for the preparation of 4-tert.-butoxybenzyl alcohol | BASF Aktiengesellschaft (DE) | 1982-09-08 | — | — | EP | claimed |
| CN-119504372-A | Method for synthesizing 4-tert-butoxy styrene | 西安近代化学研究所 | 2025-02-25 | — | — | CN | disclosed |
| CN-119504372-A | Method for synthesizing 4-tert-butoxy styrene | 西安近代化学研究所 | 2025-02-25 | — | — | CN | disclosed |
| CN-117263778-A | Preparation method of styrene series compound for 248nm photoresist | 河北凯诺中星科技有限公司 | 2023-12-22 | — | — | CN | disclosed |
| US-11440884-B2 | Compounds, salts thereof and methods for treatment of diseases | ACADIA PHARMACEUTICALS INC. (US) | 2022-09-13 | — | — | US | disclosed |
| US-8772226-B2 | Methods and compositions for the detection of cancer | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-07-08 | — | — | US | disclosed |
| EP-2612858-A1 | STAT3/5 activation inhibitor | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-07-10 | — | — | EP | disclosed |
| EP-2585068-A1 | PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN | Janssen Pharmaceutica, N.V. (BE) | 2013-05-01 | — | — | EP | disclosed |
| EP-1866290-B1 | PROKINETICIN 1 RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2013-05-01 | — | — | EP | disclosed |
| US-8362247-B2 | Prokineticin 1 receptor antagonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-01-29 | — | — | US | disclosed |
| EP-0256763-A1 | Process for azetidinones | THE UNIVERSITY OF NOTRE DAME DU LAC (US) | 1988-02-24 | — | — | EP | disclosed |
| EP-0240609-A2 | Antibiotic A 40926 N-acylaminoglucuronyl aglycons and antibiotic A 40926 aglycon | GRUPPO LEPETIT S.p.A. (IT) | 1987-10-14 | — | — | EP | disclosed |
| US-4629781-A | STRONG ACIDOLYSIS CONTROLLED BY THE USE OF SOLVENT, ACID, CONCENTRATION AND HEATING | GRUPPO LEPETIT S.P.A. (IT) | 1986-12-16 | — | — | US | disclosed |
| EP-0146053-A2 | Chemical process for preparing antibiotic L 17392 (Deglucoteicoplanin) and its salts | GRUPPO LEPETIT S.p.A. (IT) | 1985-06-26 | — | — | EP | disclosed |
| EP-0059373-B1 | PROCESS FOR THE PREPARATION OF BENZYL ALCOHOLS | BASF Aktiengesellschaft (DE) | 1984-05-23 | — | — | EP | disclosed |
| EP-0059372-A1 | Process for the preparation of 4-tert.-butoxybenzyl alcohol | BASF Aktiengesellschaft (DE) | 1982-09-08 | — | — | EP | disclosed |
| EP-0059372-A1 | Process for the preparation of 4-tert.-butoxybenzyl alcohol | BASF Aktiengesellschaft (DE) | 1982-09-08 | — | — | EP | disclosed |
| EP-0059372-A1 | Process for the preparation of 4-tert.-butoxybenzyl alcohol | BASF Aktiengesellschaft (DE) | 1982-09-08 | — | — | EP | disclosed |
| EP-0059373-A1 | Process for the preparation of benzyl alcohols | BASF Aktiengesellschaft (DE) | 1982-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11440884-B2 | Compounds, salts thereof and methods for treatment of diseases | SLC10A1, VHL, CYP11B2 | PPARA 423/4885PPARG 275/4885LTA4H 980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.